Procurement Summary
Country: Brazil
Summary: Srpp Permanent Price Registration System, for Eventual Acquisition of Pharmacological Material (Medications) in the Presentation of Pouches and Bottles, Initially Identified As: Serums and Bottles I
Deadline: 12 Jan 2026
Posting Date: 19 Dec 2025
Other Information
Notice Type: Tender
TOT Ref.No.: 132381937
Document Ref. No.: 90120/2025
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Object: Electronic Auction - Permanent Price Registration System SRPP, for possible ACQUISITION OF PHARMACOLOGICAL MATERIAL (MEDICINES) IN THE PRESENTATION OF POUCHES AND BOTTLES, INITIALLY IDENTIFIED AS: SERUMS AND BOTTLES I UASG code: 925172 Notice to from: 12/19/2025 from 08:00 to 17:59 Proposal Delivery: from 12/19/2025 at 08:00 DISTILLED WATER, STERILE AND APIROGENIC PHYSICAL APPEARANCE, PACKAGING TYPE IN CLOSED SYSTEM Quantity: 3100 CEPALEXIN, DOSAGE 50 MG/ML, PHARMACEUTICAL POWDER FORM FOR ORAL SUSPENSION Quantity: 9975 CEFALEXIN, DOSAGE 50 MG/ML, PHARMACEUTICAL FORM POWDER FOR ORAL SUSPENSION Quantity: 3325 SODIUM CHLORIDE, ACTIVE INGREDIENT 0.9%_ INJECTABLE SOLUTION, CLOSED SYSTEM APPLICATION Quantity: 65044 SODIUM CHLORIDE, PRINCIPLE ACTIVE 0.9%_ INJECTABLE SOLUTION, CLOSED SYSTEM APPLICATION Quantity: 8456 SODIUM CHLORIDE, ACTIVE INGREDIENT 0.9%_ INJECTABLE SOLUTION, CLOSED SYSTEM APPLICATION Quantity: 43899 SODIUM CHLORIDE, ACTIVE INGREDIENT 0.9%_ INJECTABLE SOLUTION, SYSTEM APPLICATION CLOSED Quantity: 6451 SODIUM CHLORIDE, ACTIVE INGREDIENT 0.9%_ INJECTABLE SOLUTION, CLOSED SYSTEM APPLICATION Quantity: 103089 SODIUM CHLORIDE, ACTIVE INGREDIENT 0.9%_ INJECTABLE SOLUTION, CLOSED SYSTEM APPLICATION Quantity: 7111 MANNITOL, DOSAGE 20%, PHARMACEUTICAL FORM INJECTABLE SOLUTION, ADDITIONAL CHARACTERISTICS CLOSED SYSTEM Quantity: 200 METRONIDAZOLE, DOSAGE 5MG/ML, INJECTABLE SOLUTION PRESENTATION Quantity: 1100 OMEPRAZOLE, CONCENTRATION 40 MG, INJECTABLE USE Quantity: 15000 OMEPRAZOLE, CONCENTRATION 40 MG, INJECTABLE USE Quantity: 5000 RINGER, COMPOSITION ASSOCIATED WITH SODIUM LACTATE, PHARMACEUTICAL FORM INJECTABLE SOLUTION, ADDITIONAL CHARACTERISTICS CLOSED SYSTEM Quantity: 20803 RINGER, COMPOSITION ASSOCIATED WITH SODIUM LACTATE, FORM PHARMACEUTICAL INJECTABLE SOLUTION, ADDITIONAL FEATURE CLOSED SYSTEM Q...
Documents
Tender Notice